AgNORs in benign, borderline and transitional cell neoplasms of the urinary bladder

APMIS

Volumn 106, Issue 10, 1998, Pages 987-992

  Misra, Vatsala ^a   Mukherjee, Jayati ^a   Gupta, Suresh C ^a   Tandon, Satyapriya ^a   Gupta, Anil K ^a  

^a MLN MEDICAL COLLEGE   (India)

Author keywords

AgNORs; Severe dysplasia; Transitional cell carcinoma

Indexed keywords

ARTICLE; CANCER GRADING; CHROMOSOME NOR; CONTROLLED STUDY; CYSTITIS; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

EID: 0031731550     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00250.x     Document Type: Article

References (29)

1. Anonymous: NORs - A new method for the pathologist (Editorial). Lancet 1987; 1: 1413-4.
2. Kanitakis J, Hoyo E, Hermier C, Chouvet B. Nucleolar organizer region enumeration in keratoacanthoma and squamous cell carcinoma of skin. Cancer 1992; 69: 2937-41.
3. Muscara M, Giuffre G, Tuccari G et al. Nucleolar organizer regions in dysplastic and neoplastic lesions of the large bowel. Eur J Basic Appl Histochem 1991; 55: 401-8.
4. Takeuchi T, Tanaka T, Ohno T, Yamamoto N, Kobayashi S, Kuriyama M, Kawada Y, Mori H. Nucleolar organizer regions in rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Virchows Arch B Cell Pathol 1990; 58: 383-7.
5. Cairns P, Suarez V, Newman J, Crocker J. Nucleolar organizer regions in transitional cell tumours of the bladder. Arch Pathol Lab Med 1989; 113: 1250-2.
6. Ruschoff J, Zimmermann R, Ulshofer B, Thomas C. Silver-stained nucleolar organizer proteins in urothelial bladder lesions. A morphometric study. Pathol Res Pract 1992; 188: 593-8.
7. Chiu KY, Loke SL, Wong KK. Improved silver technique for showing nucleolar organiser regions in paraffin wax sections. J Clin Path 1989; 42: 992-4.
8. Cotran RS, Kumar V, Robbins S L. Lower Urinary Tract. In: Robbins. Pathologic Basic of Disease. 5th ed. WB Saunders Company 1994, p. 991-1005.
9. Webb JN. Aspects of tumours of the urinary bladder and prostate glands. In: Anthony PP, MacSween RNM, editors. Recent Advances in Histopathology No. 15. Churchill Livingstone 1992; p. 157-76.
10. Crocker J, Egan MJ. Correlation between NOR sizes and numbers in non-Hodgkins lymphoma. J Pathol 1988; 156: 233-9.
11. Ayres JG, Crocker J, Skilbeck NQ. Differentiation of malignant from normal and reactive mesothelial cells using the argyrophil method for nucleolar organizer regions. Thorax 1988; 41: 366-70.
12. Yang P, Huang GS, Zhu XS. Role of nucleolar organizer regions in differentiating malignant from benign tumours of the colon. J. Clin. Pathol. 1990; 43: 235-8.
13. Hansen A, Oestergard B. AgNOR counts in intraepithelial neoplasias of endometrium. J Clin Pathol 1990; 43: 518-9.
14. Lloyd SN, Johnson CD, Brown IL, Kirk D. Nucleolar organizer regions in benign and malignant prostatic disease. Histopathology 1991; 18: 449-52.
15. Martin H, Hufnagl P, Wenzelides K, Beil M. AgNORs in cells of urothelial carcinoma of the bladder. A quantitative study using automatic microscopic image analysis. Zentralbl Pathol 1991; 137: 505-9.
16. Clement T, Visseaux-Coletto B, Adnet JJ, Ploton D, Lardennois B. Nucleolar organizers in superficial bladder tumours. Prognostic analysis of 37 observations. Prog Urol 1991; 1: 216-29.
17. Wachtler F. On the identification of active nucleolus organizing regions (NOR) in interphase, Postery Biologii Komorki 1992; 9: 233-9.
18. Tanaka T, Takeuchi T, Nishikawa A, Takami T, Mori H. Nucleolar organizer regions in hepatocarcinogenesis induced by N-2 fluorenylacetamide in rats: Comparison with bromodeoxyuridine immunohistochemistry. Jpn J Cancer Res 1989; 80: 1047-51.
19. Field DM, Fitzgerald PH, Sin FYT. Nucleolar silver staining related to cell cycle phase and cell generation of PHA-stimulated human lymphocytes. Cytobios 1984; 41: 23-33.
20. Reeves BR, Casey G, Haneycomb JR, Smith S. Correlation of differentiation state and silver staining of nucleolar organizers in the promyelocytic leukaemia cell line HL-60. Cancer Gene Cytogenet 1984; 13: 159-66.
21. Murphy WM. Diseases of the urinary bladder urethra ureters and renal pelvis. In: Murphy WM, editor. Urological Pathology. WB Saunders: Philadelphia: 1989, chapter 2.
22. Schwarzacher RT, Kraemer PM, Cram LS. Spontaneous in vitro neoplastic evolution of cultured Chinese hamster cells. Nucleolus organizing region activity. Cancer Genet Cytogenet 1988; 35: 119-28.
23. Roberts C, Brasch J, Tatterzall MHN. Ribosomal RNA gene: A selective advantage in tissue culture. Cancer Genet Cytogenet 1987; 29: 119-27.
24. Skopelitou A, Korkolopoulou P, Papanicolaou P, Christodoulou P, Thomas-Tsagli E, Pavalakis K. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinoma of the urinary bladder. Correlation with other conventional prognostic pathologic parameters. Eur Urol 1992; 23: 235-40.
25. Pich A, Chiusa L, Camina A, Navone R. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Virchows Arch 1994; 424: 143-8.
26. Helpap B, Loesevitz L, Balatko A. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinoma with special emphasis on grade II tumours. Virchows Arch 1994; 425: 265-9.
27. Zambelli S, Zanin A, Gaglio A, Zai G, Bosco E, Andrion A, Magnani C. Ki-67 scores and AgN-OR counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value. Arch Ital Urol Androl 1993; 65: 665-70.
28. Hansen AB, Bjerregaard B, Ovesen H, Horn T. AgNOR counts and histological grade in stage PTa bladder tumours: reproducibility and relation to recurrence pattern. Histopathology 1992; 20: 257-62
29. Shiina H, Shirakawa H, Yokogi H, Kishi H, Mizutani M, Igawa M, Ishibe T. Clinical value of argyrophilic nucleolar organizer regions in bladder transitional cell carcinoma. Urol Int 1995; 54: 74-9.